Multicentre registry data analysis comparing outcomes of culture-negative peritonitis and different subtypes of culture-positive peritonitis in peritoneal dialysis patients.


Journal

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
ISSN: 1718-4304
Titre abrégé: Perit Dial Int
Pays: United States
ID NLM: 8904033

Informations de publication

Date de publication:
01 2020
Historique:
entrez: 18 2 2020
pubmed: 18 2 2020
medline: 3 3 2021
Statut: ppublish

Résumé

The outcomes of culture-negative peritonitis in peritoneal dialysis (PD) patients have been reported to be superior to those of culture-positive peritonitis. The current study aimed to examine whether this observation also applied to different subtypes of culture-positive peritonitis. This multicentre registry study included all episodes of peritonitis in adult PD patients in Australia between 2004 and 2014. The primary outcome was medical cure. Secondary outcomes were catheter removal, hemodialysis transfer, relapsing/recurrent peritonitis and peritonitis-related death. These outcomes were analyzed using mixed effects logistic regression. Overall, 11,122 episodes of peritonitis occurring in 5367 patients were included. A total of 1760 (16%) episodes were culture-negative, of which 77% were medically cured. Compared with culture-negative peritonitis, the odds of medical cure were lower in peritonitis caused by Culture-negative peritonitis had superior outcomes compared to culture-positive peritonitis except for non-staphylococcal gram-positive peritonitis.

Sections du résumé

BACKGROUND
The outcomes of culture-negative peritonitis in peritoneal dialysis (PD) patients have been reported to be superior to those of culture-positive peritonitis. The current study aimed to examine whether this observation also applied to different subtypes of culture-positive peritonitis.
METHODS
This multicentre registry study included all episodes of peritonitis in adult PD patients in Australia between 2004 and 2014. The primary outcome was medical cure. Secondary outcomes were catheter removal, hemodialysis transfer, relapsing/recurrent peritonitis and peritonitis-related death. These outcomes were analyzed using mixed effects logistic regression.
RESULTS
Overall, 11,122 episodes of peritonitis occurring in 5367 patients were included. A total of 1760 (16%) episodes were culture-negative, of which 77% were medically cured. Compared with culture-negative peritonitis, the odds of medical cure were lower in peritonitis caused by
CONCLUSION
Culture-negative peritonitis had superior outcomes compared to culture-positive peritonitis except for non-staphylococcal gram-positive peritonitis.

Identifiants

pubmed: 32063153
doi: 10.1177/0896860819879891
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

47-56

Auteurs

Htay Htay (H)

Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Australia.
Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.
Australasian Kidney Trials Network, Diamantina Institute, University of Queensland, Brisbane, Australia.
Department of Renal Medicine, Singapore General Hospital, Singapore.

Yeoungjee Cho (Y)

Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Australia.
Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.
Australasian Kidney Trials Network, Diamantina Institute, University of Queensland, Brisbane, Australia.

Elaine M Pascoe (EM)

Australasian Kidney Trials Network, Diamantina Institute, University of Queensland, Brisbane, Australia.

Carmel Hawley (C)

Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Australia.
Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.
Australasian Kidney Trials Network, Diamantina Institute, University of Queensland, Brisbane, Australia.
Translational Research Institute, Brisbane, Australia.

Philip A Clayton (PA)

Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Australia.
Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Australia.
School of Medicine, Faculty of Health Sciences, University of Adelaide, Australia.

Monique Borlace (M)

Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Australia.

Sunil V Badve (SV)

Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Australia.
Department of Nephrology, St George Hospital, Sydney, Australia.

Kamal Sud (K)

Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Australia.
Department of Renal Medicine, Nepean and Westmead Hospitals, Sydney, Australia.
University of Sydney Medical School, Australia.

Neil Boudville (N)

Medical School, University of Western Australia, Australia.

Jenny Hc Chen (JH)

Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Australia.
School of Medicine, University of New South Wales, Sydney, Australia.
Department of Nephrology, Wollongong Hospital, Australia.

Matthew Sypek (M)

Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Australia.
Department of Nephrology, Royal Melbourne Hospital, Victoria, Australia.

David W Johnson (DW)

Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Australia.
Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.
Australasian Kidney Trials Network, Diamantina Institute, University of Queensland, Brisbane, Australia.
Translational Research Institute, Brisbane, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH